Loading…
SBC Medical Group Holdings Incorporated is projected to rise to $3.73 by 2027, a +20% move from its current price of $3.10. SBC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.00 | $3.10 | $3.21 | +0.06% |
| May 30 | $2.96 | $3.10 | $3.26 | +0.12% |
| May 31 | $2.93 | $3.11 | $3.29 | +0.17% |
| Jun 1 | $2.90 | $3.11 | $3.32 | +0.23% |
| Jun 2 | $2.88 | $3.11 | $3.35 | +0.29% |
| Jun 3 | $2.86 | $3.11 | $3.38 | +0.35% |
| Jun 4 | $2.85 | $3.11 | $3.40 | +0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.85 | $3.11 | $3.40 | +0.41% |
| Week 2 | $2.75 | $3.13 | $3.55 | +0.82% |
| Week 3 | $2.69 | $3.14 | $3.66 | +1.23% |
| Week 4 | $2.63 | $3.15 | $3.77 | +1.64% |
| Week 5 | $2.59 | $3.16 | $3.87 | +2.06% |
| Week 6 | $2.55 | $3.18 | $3.96 | +2.48% |
| Week 7 | $2.52 | $3.19 | $4.04 | +2.89% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company owns and operates treatment centers under the SBC brand and offers a wide range of business support services tied to franchisees and clinic operations.
The company delivers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; laser hair removal; and a range of other cosmetic procedures.
SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.
SBC Medical Group Holdings Incorporated trades in the Industrials category and is listed with a current price of $3.07 and a market capitalization of $315.74M, ranking at 3474. The stock sits in a defined price range and carries a neutral near-term technical posture, with a price outlook that shows potential upside across the multi-year forecast. The company’s current price and market position anchor a trajectory that the forecast envisions expanding in the coming years.
Forecasts indicate the average price path grows over time, with 2027 avg $3.72 and 2028 avg $3.71, moving toward higher averages by 2031–2035 and beyond. The long-range view shows average prices of $6.98 by 2040 and $14.03 by 2050, accompanied by bullish sentiment flags in later years and sizable potential ROI in the long run.
A major floor 39.8% below — a decisive break under it would weaken the trend.
The nearest floor, 7.4% below — buyers have tended to step in here.
The nearest ceiling, 44.8% above — a clean break opens room to run.
A major ceiling 64.7% above — clearing it would confirm fresh momentum.
Key SBC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SBC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.12 | Sell | $3.09 | Buy |
| MA 10 | $3.06 | Buy | $3.10 | Sell |
| MA 20 | $3.15 | Sell | $3.21 | Sell |
| MA 50 | $3.64 | Sell | $3.51 | Sell |
| MA 100 | $3.94 | Sell | $3.74 | Sell |
| MA 200 | $3.97 | Sell | $4.07 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.52 | Neutral |
| Stoch RSI (14) | 82.26 | Sell |
| CCI (20) | -30.88 | Neutral |
| Williams %R (14) | -47.73 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | -2.52 | Sell |
| Bollinger %B (20,2) | 0.40 | Neutral |
| Stochastic %K (14) | 52.27 | Neutral |
| TRIX (15) | -0.84 | Sell |
| Awesome (5,34) | -0.33 | Sell |
| Ultimate (7,14,28) | 50.51 | Neutral |
| Momentum (10) | -0.21 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 3.14 | Sell |
| ADX (14) | 29.43 | Sell |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is NEUTRAL. The RSI14 stands at 40, suggesting modest upward momentum rather than overbought conditions.
Price is trading around the 50-day simple moving average at $3.65 and near the 200-day simple moving average at $3.98, indicating a nuanced balance between near-term support and resistance. The established support level is $2.87 and the resistance is $4.49, framing a trading range that investors will watch for short-term clues.
Over the last 30 days, the stock has traded within a low of $2.42 and a high of $3.89, reflecting a relatively narrow performance window in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.87 | $3.10 | $4.51 | 0% | Neutral | |
| $2.89 | $3.73 | $5.13 | +20% | Bullish | |
| $2.82 | $3.77 | $5.42 | +22% | Bullish | |
| $2.52 | $3.47 | $5.16 | +12% | Neutral | |
| $2.53 | $3.57 | $5.46 | +15% | Neutral | |
| $2.93 | $4.23 | $6.64 | +37% | Bullish | |
| $3.23 | $4.78 | $7.66 | +54% | Bullish | |
| $3.44 | $5.19 | $8.49 | +67% | Bullish | |
| $3.31 | $5.10 | $8.50 | +65% | Bullish | |
| $3.10 | $4.88 | $8.27 | +57% | Bullish | |
| $4.08 | $7.02 | $12.77 | +126% | Bullish | |
| $6.81 | $13.75 | $27.72 | +344% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.87 | $3.10 | $3.68 | +0.00% |
| June 2026 | $2.78 | $3.28 | $3.98 | +5.95% |
| July 2026 | $2.74 | $3.27 | $4.03 | -0.47% |
| August 2026 | $2.68 | $3.23 | $4.03 | -1.22% |
| September 2026 | $2.77 | $3.35 | $4.23 | +3.86% |
| October 2026 | $2.82 | $3.44 | $4.38 | +2.62% |
| November 2026 | $2.77 | $3.40 | $4.36 | -1.21% |
| December 2026 | $2.83 | $3.49 | $4.51 | +2.52% |
Click any year to see its month-by-month SBC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SBC could reach as high as $4.51, with a base case around $3.10 and support toward $2.87 — roughly 0% from $3.10. A consolidation phase looks the most probable path here.
Expect SBC to range from $2.89 to $5.13 through 2027. The $3.73 average target implies a +20% move from current prices. That is up +20% on the projected 2026 average. Momentum favours further upside here.
The SBC price prediction for 2028 points to an average of $3.77 (low $2.82, high $5.42) — a potential gain of +22% on today's $3.10. Buyers look set to stay in control over this stretch.
In 2029, SBC is projected to trade between $2.52 and $5.16, averaging $3.47 — a potential gain of +12% from today's $3.10. That is -8% versus the projected 2028 average. Price action looks broadly range-bound.
SBC Medical Group Holdings Incorporated's 2030 outlook centres on $3.57, within a $2.53 to $5.46 range. That is up +3% on the projected 2029 average. That marks a +15% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, SBC could reach as high as $6.64, with a base case around $4.23 and support toward $2.93 — roughly +37% from $3.10. Momentum favours further upside here.
Expect SBC to range from $3.23 to $7.66 through 2032. The $4.78 average target implies a +54% move from current prices. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The SBC price prediction for 2033 points to an average of $5.19 (low $3.44, high $8.49) — a potential gain of +67% on today's $3.10. Momentum favours further upside here.
In 2034, SBC is projected to trade between $3.31 and $8.50, averaging $5.10 — a potential gain of +65% from today's $3.10. That is -2% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
SBC Medical Group Holdings Incorporated's 2035 outlook centres on $4.88, within a $3.10 to $8.27 range. That is -4% versus the projected 2034 average. That marks a +57% change versus current levels. Momentum favours further upside here.
By 2040, SBC could reach as high as $12.77, with a base case around $7.02 and support toward $4.08 — roughly +126% from $3.10. Buyers look set to stay in control over this stretch.
Expect SBC to range from $6.81 to $27.72 through 2050. The $13.75 average target implies a +344% move from current prices. That is up +96% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SBC today (≈ 322.580645 SBC) could be worth
$4,436.14
+$3,436.14 (+344%) by 2050 · US Dollar
Based on the average projected SBC price of $13.75 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SBCwould be worth at today's price.
$1,000 invested in SBC on May 27, 2025 (≈ 217.391309 SBC) would be worth
$673.91
-$326.09 (-32.6%) today · 0.67× · US Dollar
Based on a SBC entry price of $4.6 vs. today's $3.1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.23 | $959.75 | -4.0% |
| 1 month ago | $3.38 | $917.16 | -8.3% |
| 3 months ago | $3.89 | $796.92 | -20.3% |
| 6 months ago | $3.57 | $868.35 | -13.2% |
| 1 year ago | $4.6 | $673.91 | -32.6% |
| All time (3.7y) ago | $9.96 | $311.24 | -68.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SBC forecast.
Our base-case forecast reaches $6.20 around 2040.
Implied market cap at $6.20: $637.65M
The multi-year forecast shows a gradual rise in projected averages across the horizon. The 2026 forecast sits at an average of $3.07 with a neutral sentiment. By 2027 the average rises to $3.72 and 2028 to $3.71, with ROI values of 21 and a bullish tone.
The 2030 forecast yields an average of $3.53 and a 14.9 ROI with neutral sentiment, while 2031–2035 show continued upside momentum and bullish sentiment, reaching $4.22 (ROI 37.4) in 2031, $4.82 (ROI 57) in 2032, $5.19 (ROI 69) in 2033, $5.08 (ROI 65.5) in 2034, and $4.89 (ROI 59.1) in 2035.
In 2040 the forecast calls for an average of $6.98 with a 127.2 ROI and bullish sentiment, followed by a dramatic rise in 2050 to an average of $14.03 with a 356.9 ROI and bullish sentiment. These projections represent estimates, not guarantees, and hinge on market dynamics and company performance that can change over time. Investors should consider the long-run upside alongside the inherent uncertainty of forward-looking forecasts.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $3.53 with an ROI of 14.9 and a Neutral sentiment. The 2030 range is projected from $2.46 to $5.47.
The forecast features bullish sentiment in multiple later years, with 2040 and 2050 showing strong average prices of $6.98 and $14.03 and ROIs of 127.2 and 356.9 respectively. However, the outlook notes uncertainty and these are estimates, not guarantees.
Yes. The 2030 forecast lists a max of $5.47, and the 2032–2033 windows show higher highs, including $7.85 in 2032 and $8.63 in 2033, with continued upside into 2040 and beyond.
The current price is $3.07 and the market capitalization is $315.74M. The stock is ranked 3474.
The 2050 forecast shows an average price of $14.03 with a max of $28.98 and an ROI of 356.9, with bullish sentiment.
SBC Medical Group Holdings Incorporated Community Discussion
0Share your SBC Medical Group Holdings Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.